Recombinant EBV P138 Protein [His] (VAng-0612Lsx)
EBV p138 Early Antigen D (EA-D) Protein, recombinant protein from E. coli. 1.00 mg/mL.
Target
Epstein-Barr Virus
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
6 M Urea, 20 mM Phosphate, pH 8 - 1 M Sodium Chloride, 0.1% Polyoxyethylene(10)Tridecylether.
Purity
> 95 % pure by SDS-PAGE.
Introduction
The Epstein–Barr virus (EBV), also called human herpesvirus 4 (HHV-4), is named after Michael Anthony Epstein. It is one of the eight known human herpesvirus types in the herpes family, and is common in human diseases. It is best known as the cause of infectious mononucleosis (glandular fever). It is also associated with particular forms of cancer. There is evidence that infection with EBV is associated with a higher risk of certain autoimmune diseases. Some 200,000 cancer cases per year are thought to be attributable to EBV.
Alternative Names
Epstein–Barr virus; Herpesviridae; Gammaherpesvirinae; Lymphocryptovirus; Human herpesvirus 4; HHV-4; EBV; p18 protein
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.